INTELLIGENT BIO SOLUTIONS INC. Interest Expense Nonoperating
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Interest Expense Nonoperating of $10.74 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. interest expense nonoperating for the quarter ending 2026-06-30 was $3.30K, a 37.86% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. interest expense nonoperating for the quarter ending 2026-03-31 was $4.24K, a 46.45% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. interest expense nonoperating for the quarter ending 2025-12-31 was $56.21K, a 316.30% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. interest expense nonoperating for the quarter ending 2025-09-30 was $3.90K, a 82.52% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. interest expense nonoperating for fiscal 2026 was $10.74K, a 59.24% decline from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. interest expense nonoperating for fiscal 2025 was $26.34K, a 84.24% decline from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. interest expense nonoperating for fiscal 2024 was $167.14K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 9 month as first filed | Interest Expense Nonoperating 12 month | Interest Expense Nonoperating 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $7.54K derived: sum of 2 quarters · filed 2026-08-19 | $63.75K derived: sum of 3 quarters · filed 2026-08-19 | $10.74K 10-K · filed 2026-08-19 | |||
| 2026-03-31 | $4.24K 10-Q · filed 2026-05-13 | $60.45K derived: sum of 2 quarters · filed 2026-05-13 | $7.43K 10-Q · filed 2026-05-13 | $69.67K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | $56.21K 10-Q · filed 2026-02-12 | $60.11K 10-Q · filed 2026-02-12 | $65.42K derived: sum of 3 quarters · filed 2026-08-19 | $73.34K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-09-30 | $3.90K 10-Q · filed 2025-11-12 | $9.21K derived: sum of 2 quarters · filed 2026-08-19 | $17.13K derived: sum of 3 quarters · filed 2026-08-19 | $30.64K derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | $5.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $13.23K derived: sum of 2 quarters · filed 2026-08-19 | $26.73K derived: sum of 3 quarters · filed 2026-08-19 | $26.34K 10-K · filed 2026-08-19 | $60.89K 10-K · filed 2025-08-15 | ||
| 2025-03-31 | $7.92K 10-Q · filed 2026-05-13 | $15.00K 10-Q · filed 2025-05-13 | $21.42K derived: sum of 2 quarters · filed 2026-05-13 | $21.03K 10-Q · filed 2026-05-13 | $50.83K 10-Q · filed 2025-05-13 | $98.30K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $13.50K 10-Q · filed 2026-02-12 | $35.83K 10-Q · filed 2026-02-12 | $90.38K derived: sum of 3 quarters · filed 2026-02-12 | $133.05K derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-09-30 | $22.33K 10-Q · filed 2025-11-12 | $76.88K derived: sum of 2 quarters · filed 2025-11-12 | $119.55K derived: sum of 3 quarters · filed 2025-11-12 | $152.02K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $54.55K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $97.22K derived: sum of 2 quarters · filed 2025-08-15 | $129.69K derived: sum of 3 quarters · filed 2025-08-15 | $167.14K 10-K · filed 2025-08-15 | |||
| 2024-03-31 | $42.67K 10-Q · filed 2025-05-13 | $75.14K derived: sum of 2 quarters · filed 2025-05-13 | $112.59K 10-Q · filed 2025-05-13 | ||||
| 2023-12-31 | $32.47K 10-Q · filed 2025-02-13 | $69.92K 10-Q · filed 2025-02-13 | |||||
| 2023-09-30 | $37.45K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |